Hypoxia-inducible factor-1α and the glycolytic phenotype in tumors

Neoplasia

Volumn 7, Issue 4, 2005, Pages 324-330

  Robey, Ian F ^a   Lien, Anthony D ^a   Welsh, Sarah J ^a   Baggett, Brenda K ^a   Gillies, Robert J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Glucose consumption; Glycolysis; Hypoxia inducible factor; Lactate; Warburg effect

Indexed keywords

GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VON HIPPEL LINDAU PROTEIN;

AEROBIC METABOLISM; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; METASTASIS; OXYGENATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; REGULATORY MECHANISM;

EID: 18644366801     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.04430     Document Type: Article

References (41)

1. Warburg O (1956). On the origin of cancer cells. Science 123, 309-314.
2. Czernin J and Phelps ME (2002). Positron emission tomography scanning: current and future applications. Annu Rev Med 53, 89-112.
3. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, and Phelps MEA (2001). Tabulated summary of the FDG PET literature. J Nucl Med 42, 1S-93S.
4. Raghunand N, Gatenby RA, and Gillies RJ (2003). Microenvironmental and cellular consequences of altered blood flow in tumors. Br J Radiol 76, S11-S22.
5. Kirkpatrick JP, Brizel DM, and Dewhirst MW (2003). A mathematical model of tumor oxygen and glucose mass transport and metabolism with complex reaction kinetics. Radiat Res 159, 336-344.
6. Kimura H, Braun RD, Ong ET, Hsu R, Secomb TW, Papahadjopoulos D, Hong K, and Dewhirst MW (1996). Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 56, 5522-5528.
7. Weidner N, Semple JP, Welch WR, and Folkman J (1991). Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324, 1-8.
8. Fox SB (1997). Tumour angiogenesis and prognosis. Histopathology 30, 294-301.
9. Gillies RJ, Schornack PA, Secomb TW, and Raghunand N (1999). Causes and effects of heterogeneous perfusion in tumors. Neoplasia 1, 197-207.
10. Semenza GL and Wang GL (1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12, 5447-5454.
11. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, and Ratcliffe PJ (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275.
12. 2 sensing. Science 292, 464-468.
13. Semenza GL (2001). HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107, 1-3.
14. 2 homeostasis. Curr Opin Genet Dev 8, 588-594.
15. 2-regulated prolyl hydroxylation. Science 292, 468-472.
16. Semenza GL, Roth PH, Fang HM, and Wang GL (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269, 23757-23763.
17. Ebert BL, Firth JD, and Ratcliffe PJ (1995). Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct asacting sequences. J Biol Chem 270, 29083-29089.
18. Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW, and Ratcliffe PJ (1997). Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 94, 8104-8109.
19. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, et al. (2000). Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60, 7075-7083.
20. Levy AP, Levy NS, Wegner S, and Goldberg MA (1995). Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270, 13333-13340.
21. Semenza GL (1994). Regulation of erythropoietin production. New insights into molecular mechanisms of oxygen homeostasis. Hematol Oncol Clin North Am 8, 863-884.
22. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, and Simons JW (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59, 5830-5835.
23. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, et al. (2000). Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24, 227-235.
24. Ellison G, Klinowska T, Westwood RF, Docter E, French T, and Fox JC (2002). Further evidence to support the melanocytic origin of MDA-MB-435. Mol Pathol 55, 294-299.
25. Sellappan S, Grijalva R, Zhou X, Yang W, Eli MB, Mills GB, and Yu D (2004). Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line. Cancer Res 64, 3479-3485.
26. + diffusion to the acidic pH of tumors. Neoplasia 5, 135-145.
27. Chen J, Zhao S, Nakada K, Kuge Y, Tamaki N, Okada F, Wang J, Shindo M, Higashino F, Takeda K, et al. (2003). Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol 162, 1283-1291.
28. Welsh S, Williams R, Kirkpatrick L, Paine-Murrieta G, and Powis G (2004). Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha. Mol Cancer Ther 3, 233-244.
29. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, and Semenza GL (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16, 4604-4613.
30. Paweletz N and Knierim M (1989). Tumor-related angiogenesis. Crit Rev Oncol Hematol 9, 197-242.
31. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, et al. (1998). Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485-490.
32. Sourvinos G, Miyakis S, Liloglou TL, Field JK, and Spandidos DA (2001). Von Hippel-Lindau tumour suppressor gene is not involved in sporadic human breast cancer. Tumour Biol 22, 131-136.
33. Chan DA, Sutphin PD, Denko NC, and Giaccia AJ (2002). Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J Biol Chem 277, 40112-40117.
34. Karni R, Dor Y, Keshet E, Meyuhas O, and Levitzki A (2002). Activated pp60c-Src leads to elevated hypoxia-inducible factor (HIF)-1alpha expression under normoxia. J Biol Chem 277, 42919-42925.
35. Minet E, Mottet D, Michel G, Roland I, Raes M, Remade J, and Michiels C (1999), Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction. FEBS Lett 460, 251-256.
36. Isaacs JS, Jung YJ, Mimnaugh EG, Martinez A, Cuttitta F, and Neckers LM (2002). Hsp90 regulates a von Hippel Lindau - independent hypoxia-inducible factor-1 alpha-degradative pathway. J Biol Chem 277, 29936-29944.
37. Lu H, Forbes RA, and Verma A (2002). Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277, 23111-23115.
38. Bos R, van Der Hoeven JJ, van Der Wall E, van Der Groep P, van Diest PJ, Comans EF, Joshi U, Semenza GL, Hoekstra OS, Lammertsma AA, et al. (2002). Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol 20, 379-387.
39. Gatenby RA and Gawlinski ET (2003). The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Res 63, 3847-3854.
40. Berggren M, Gallegos A, Gasdaska JR, Gasdaska PY, Warneke J, and Powis G (1996). Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res 16, 3459-3466.
41. Pfaffl MW (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45.